期刊文献+

非小细胞肺癌组织ET-1、VEGF及MVD的表达及相互关系 被引量:8

Expression of endothelin,vascular endothelial growth factor and microvessel density in non-small cell lung cancer tissue
下载PDF
导出
摘要 目的:研究非小细胞肺癌(NSCLC)组织中内皮素-1(ET-1)、血管内皮生长因子(VEGF)的表达和微血管密度(MVD),以探讨ET-1、VEGF在肺癌组织血管形成中的调节作用。方法:采用免疫组化和图像分析技术,检测40例NSCLC组织标本中ET-1、VEGF的表达及MVD。结果:ET-1、VEGF在NSCLC组织表达率分别为55%(22/40)、62%(25/40),显著高于肺良性病变组8%(1/12)、0%(0/12)及正常对照组(0/10)、(0/10)(P<0.01);ET-1、VEGF表达阳性组MVD(26.23±3.52、23.40±5.29)显著高于ET-1、VEGF表达阴性组(15.46±4.85、16.40±3.85);ET-1、VEGF表达和MVD在低、中、高分化癌中存在显著差异[ET-1(0.212±0.031vs0.147±0.015vs0.103±0.032)、VEGF(0.267±0.023vs0.166±0.021vs0.112±0.012)、MVD(26.75±3.20vs23.14±3.38vs16.15±3.22)](P<0.01或P<0.05);淋巴结转移阳性组ET-1、VEGF表达和MVD值显著高于阴性组[ET-1(0.198±0.037vs0.141±0.032)、VEGF(0.256±0.022vs0.154±0.037)、MVD(27.62±3.58vs17.13±3.13)](P<0.01或P<0.05)。结论:ET-1、VEGF调控肺癌组织血管形成,促进肿瘤的生长和转移。 Objective:To explore the formation of blood vessels in non -small cell lung cancer(NSCLC) and the expression of endothelin - 1 ( ET - 1 ), vascular endothelial growth factor (VEGF) and microvessel density ( MVD ) in NSCLC. Methods : ET - 1, VEGF expression and MVD were detected by immuno - histochemistry and image analysis technique in 40 cases of NSCLC tissue. Results: The ET - 1, VEGF positive expression were mainly located in the cytoplasm of lung cancer. The positive rate of ET - 1, VEGF in NSCLC was significantly higher than that in normal and benign lesion (55% vs 8% vs 0% and 62% vs 0% vs 0% ) (P 〈0.01). MVD was notably higher in ET - 1 ,VEGF positive expression tissues (26.23 ± 3.52 vs 15.46 ± 4.85,23.40 ± 5.29 vs 16.40 ± 3.85 ) ( P 〈 0.01 ). ET - 1, VEGF and MVD expression in low and middle and high differentiation lung cancer were significantly different [ ET - 1(0.212±0.031 vs0.147 ±0.015 vs0. 103 ±0.032), VEGF ( 0. 267 ± 0. 023 vs0.166±0.021 vs0.112 ± 0.012)and MVD(26.75 ± 3.20 vs 23. 14 ± 3.38 vs 16.15 ± 3.22) ] (P 〈 0.01 or P 〈 0.05 ). ET - 1, VEGF expression and the MVD value of lymph node postitive group were remarkably higher than that of the negative group. Conclusion: ET - 1, VEGF may contribute to neovascularization of lung cancer as a angiogenic regulator and might play an important role in tumor angiogenesis.
出处 《现代肿瘤医学》 CAS 2009年第10期1881-1884,共4页 Journal of Modern Oncology
关键词 非小细胞肺癌 内皮素-1 血管内皮生长因子 微血管密度 免疫组化 non - small cell lung cancer ( NSCLC ) endothelin - 1 ( ET - 1 ) vascular endothelial growth factor(VEGF) microvessel density ( MVD ) immuno - histochemistry
  • 相关文献

参考文献9

  • 1Weidner N. Intratumor microvessel density as a prognostic factor in cancer [ J ]. Am J Pathol, 1995,147 ( 1 ) :9 - 19.
  • 2Yanagisawa M, Kurihara H, Kimura S, et al. A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca^2 + channels[ J]. J Hypertens Suppl, 1988,6(4) :S188 - 191.
  • 3Shichiri M, Hirata Y, Nakajima T, et al. Endothelin -1 is an autocrine/paracrine growth factor for human cancer cell lines [ J ]. J Clin Invest,1991,87(5) :1867 - 1871.
  • 4朱静,万远廉,刘玉村,张剑权.血管生成与肿瘤[J].现代肿瘤医学,2007,15(3):428-430. 被引量:10
  • 5Ushijima C, Tsukamoto S, Yamazaki K, et al. High vascularity in the peripheral region of non - small cell lung cancer tissue is associated with tumor progression[ J], Lung Cancer,2001,34 (2) :233 -241.
  • 6安莉,王静,俞森洋.COX-2、VEGF在NSCLC中的表达及与微血管生成的关系[J].现代肿瘤医学,2007,15(2):169-172. 被引量:6
  • 7Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor is associated with neovaseularization and influences progression of non - small cell lung carcinoma [ J ]. Clin Cancer Res, 1997,3 (6) :861 - 865.
  • 8Folkman J. What is the evidence that tumors are ang4ogenesis dependent[ J] ? J Nail Cancer Inst,1990,82( 1 ) :4 -6.
  • 9Giaid A, Hamid QA, Springall DR, et al. Detection of endothelin immunoreactivity and mRNA in pulmonary turnouts[ J]. J Pathol, 1990,162 ( 1 ) : 15 - 22.

二级参考文献15

  • 1Saito H,Tsujitani S,Kondo A,et al.Tumor vascularity as a prognostic factor in cancer patients[J].Surgery,1999,125:195.
  • 2Cao Y,Prescott SM.Many actions of cyclooxygenase-2 in cellular dynamics and in cancer[J].J Cell Physiol,2002,190:279 ~286.
  • 3Hida T,Yatabe Y,Achiwa H,et al.Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers,specifically in adenocarcinomas[J].Cancer Res,1998,58:3761 ~ 3764.
  • 4Shinanuki Y,Takahashi K,Cui R,et al.Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer[J].Lung,2005,183 (1):29 ~ 42.
  • 5Voelkel NF,Vandivier RW,Tuder RM.Vascular endothelial growth factor in the lung[J].Am J Physiol Lung Cell Mol Physiol,2006,290(2):L209 ~221.
  • 6Offersen BV,Borre M,Overgaard J.Quantification of angiogenesis as a prognostic marker in human carcinomas:a critical evaluation of histopathological methods for estimation of vascular density[J].Eur J Cancer,2003,39(7):881 ~890.
  • 7Brinckerboff CE,Matrisian LM.Matrix metalloproteinases:a tail of a frog that became a prince[J].Nat Rev Mol Cell Biol,2002,3(3):207~214.
  • 8Kumar R,Yoneda J,Bucana CD,et al.Regulation of distinct steps of angiogenesis by different angiogenic molecules[J].Int J Oncol,1998,12(4):749~757.
  • 9Egeblad M,Werb Z.New functions for the matrix metalloproteinases in cancer progression[J].Nat Rev Cancer,2002,2(3):161~174.
  • 10Pepper MS.Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis[J].Artemscler Thromb Vasc Biol,2001,21(7):1104~1117.

共引文献12

同被引文献75

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部